Consumer Dispensing and Drug Delivery Solutions and Services

A global leader in consumer product dispensing and drug delivery solutions and services

2

3

Aptar’s essential products and solutions transform and enhance user experiences around the world and in some cases, even save lives.

Years of Experience 75

In consumer product dispensing and drug delivery

1940 - 1960 1960 - 1980 1980 - 2000 TodayOur entrepreneurial founding companies started in the U.S, France and Germany

Pittway Corporation acquires the legacy companies and grows the company

Debut of the name Aptar and continued global expansion. Aptar becomes a public company in 1993.

$2.9 billion in revenuewith +14,000 employees in 20 different countries

• Entrepreneurial spirit and culture of innovation• Adaptive strategies in attractive markets• Evolving, growing geographic presence• Improving consumer and patient experiences• Steady, long-term value creator• Conversion to dispensing and new drug delivery

formats on top of GDP growth

4

Aptar TodayOver 14,000 dedicated employees in 20 countries

• Europe: 8,700• Asia/South America: 2,900• North America: 2,400

Aptar SnapshotBROAD PRODUCT PORTFOLIO

SALES BY MARKET SALES BY REGION

A sample of Aptar’s 5,000+ global customers

6%57%

8%

29%

DIVERSE CUSTOMER BASE

6

Executive Committee

Stephan TandaPresident and CEO

Robert KuhnExecutive Vice President

and CFO

Eldon SchafferExecutive Vice President,

Strategic Projects and Commercial Excellence

Marc Prieur President, Aptar Beauty + Home

Gael TouyaPresident, Aptar Pharma

Shiela VinczellerChief Human Resources

Officer

Xiangwei GongPresident, Aptar Asia

Hedi Tlili President, Aptar Food + Beverage

7

Kimberly ChaineyExecutive Vice President, Global General Counsel

8

We reimagine packaging solutions to improve everyday life for people everywhere.P U R P O S E

We partner with our customers to help them win with differentiated solutions. We access the expertise of the world to innovate.We care for our planet.We have talented, passionate, diverse people who thrive in our inclusive culture.We always live our Core Values.

We respect and trust people.We believe in the self-worth of individuals regardless of their status.We strive for relationships that are based on openness, honesty, and feedback.We promote teamwork and cooperation at all levels.We challenge people to develop their potential and to take initiative.We practice business relationships that are based on responsibility and on long-term and mutual interests to all stakeholders.

V I S I O NC O R E V A L U E S

Strategic Priorities

Macro Trends

• Aging Population• Connectivity

• E-Commerce Supply Chain • Health and Wellness

• Sustainability• Urbanization

• Rise of Eastern Economies• Shareholder Engagement

Organic Growthadded focus on high growth regions

Talent & Leadershipadded focus on inclusion and diversity

Innovation, Operat ions & Commercial Excel lence

Successful TransformationBeauty + Home & Corporate Functions

Acquisi t ions & Partnerships

2017Financial (five year avg)Sales Growth 3%EBITDA Margin 19%

AcquisitionsStrategic technologies in the US and EU

TalentEvolving need for greater capabilities and diversity

Geographic FocusAmericas & EU

Strategic Priorities2022Financial Sales Growth 4-7%EBITDA Margin 20-22%

Acquisitions/PartnersGlobal acquisitions, partnerships, incubators, new business models

TalentGreater diversity, inclusion and global capabilities

Geographic FocusAdded emphasis on Asia/Middle East/Eastern EU

9

ESG Recognitions

10

• America’s Most Responsible Companies 2020 by Newsweek

• Number 48 of the Top 100 Most Sustainable Companies in America by Barron’s for 2020; second year on the list

Our CapabilitiesExcellence Pillars• Innovation• Operations• Commercial

11

Positioning Aptar for Sustained Growth in Asia

12

Our Presence in Asia

13

Aptar Guangzhou

Aptar Hyderabad

Aptar Footprint

Select Customers

Recent Investment in Asia

Tokyo

Aptar Asia

Key Growth Drivers

SKIN CARE AND COLOR COSMETICS Boom driven by “affordable luxury”, rising middle class and increase in image consciousness

RAPIDLY AGING POPULATIONAdding strain to healthcare systems and need for new models to deliver medical treatments; Need to look and feel young fuels demand for beauty products and healthy nutritious foods

MADE IN ASIA FOR ASIADemand for novelty by local consumers driving shorter product lifecycles and need for local production

ECONOMIC SCALEChina and India will be the two largest global economies by 2030

14

SUSTAINABILITY HEALTH ANDWELLNESS CONNECTIVITY URBANIZATION CHANGING

DEMOGRAPHICSE-COMMERCE /

INDIVIDUALIZATION

15

Macro Trends Supporting Our Business

Custom Packaging Double Serum

Innovations That Improve & Save Lives

16

Active Packaging Technologies

SensimistCustom Pouch Fitment and Closure with SimpliSqueeze®

ValveCustom Pour Spout

Closure

Sustainable Solutions (Custom Flip-Top

Closure 50% PCR)

Conversion From Non-Dispensing to Dispensing

17

Upright bottle with Aptar’sdispensing closure

Aptar’s Flip Top Dispensing Closure with SimpliSqueeze® ValveGlass bottle

Innovative Solutions that Can Save Lives

18

Syringe Aptar’s Unidose nasal spray delivery

Injectable

Product Evolution: Spray Sunscreen

19

Aptar’s Disc-top closure Aptar’s Bag-on-valve and twist-lock actuator

Jar

Aptar Financials

20

21

2,317 $2,331 $2,469$2,765 $2,860

$0

$1,000

$2,000

$3,000

$4,000

2015 2016 2017 2018 2019

Sales(in millions $)

$454 $476 $475

$592

$0

$200

$400

$600

2015 2016 2017 2018 2019

Adjusted EBITDA(in millions $)

$3.00 $3.13 $3.44$4.00 $3.95

$0

$1

$2

$3

$4

$5

2015 2016 2017 2018 2019

Adjusted EPS(in millions $)

$174$196

$168

$102

$272

$0

$100

$200

$300

2015 2016 2017 2018 2019

Free Cash Flow(in millions $)

$551

$71 $77 $80 $82$90

$0

$40

$80

$120

2015 2016 2017 2018 2019

Annual Cash Dividends (in millions $)

19.6% 20.4% 19.2% 19.9% 20.7%

0%

10%

20%

30%

2015 2016 2017 2018 2019

Adjusted EBITDA Margin(%)

Five Year Financial Snapshot

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Long Term Value Creator2009-2019

22*Please see 2019 Reconciliation of Non-GAAP Financial Measures under investors.aptar.com under Events & Presentations** As of Dec. 31, 2019, Aptar’s market capitalization was approximately $7.3 Billion

**

Total Shareholder Returns(Dividends Reinvested)

Source: Standard & Poor’s; Peer Group Represents Aptar’s Current Proxy Peer Group of 20 Companies 23

Dec-14 Dec-15 Dec-16 Dec-17 Dec-18 Dec-19AptarGroup 100 110.61 113.66 135.62 149.93 186.62S&P 500 Index 100 101.38 113.51 138.29 132.23 173.86

$0

$50

$100

$150

$200

$250

Full Year 2019 Sales, EPS and Adjusted EPS

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures. 24

Consolidated Financial Targets

25

Metric3 Year

Average 2019Long-term

TargetCore sales growth1 5% 3% 4-7%

Adj. EBITDA2 /Sales % 20% 21% 20-22%

ROIC3 13% 11% 13-15%

Dividend Payout Ratio 35% 36% 30-40%

Leverage Ratio ≈ 2X ≈ 2X 1-3X1 – Excludes acquisitions and currency effects. 2 – Adjusted EBITDA (earnings before net interest, taxes, depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting adjustments.

3 – Return on invested capital = adjusted earnings before net interest and taxes, less tax effect / average capital (average of beginning of year and end of year capital) [capital = equity plus debt less cash].

4 – Cash dividends paid / adjusted earnings per share.

Balanced Capital AllocationInvesting in our business and returning value to shareholders

26

Dividends$0.4B15%

Acquisitions$0.8B31%

Capex$0.9B35%

Repurchases$0.5B19%

2015 - 2019 Capital Allocation

$2.6B

Environmental, Social, Governance (ESG)

27

Sustainability Progress

28

Better identifying new material opportunities

for future products

Better measuring the impacts of existing

products

One of Barron’s Top 100 Most

Sustainable U.S. Companies

(2020 & 2019)

We invite you to read our 2018 Corporate Sustainability Report on our website.

Designed to Recycle

Partnering with global organizations working

toward a circular economy

Americas Most Responsible

Companies 2020 Newsweek

ESG rating of “A” by MSCI ESG Research

LLC

29

Stock Black Closure Portfolio (PCR)

Designed to improve recyclability

Mono Material / Resin Conversion

Stay-with / Tethered Post Consumer Recycled (Food grade)

Designed to improve reusability

Sustainable Product Strategy

Innovative Solutions for a Sustainable Future

30

PCR and recyclable closure Lotion pump on a refillable bottle

PCR Closure

As a signatory of the Ellen MacArthur Foundation’s New Plastics Economy, we’ve set targets and made strong public commitments:

• Aptar will achieve 10% recycled content by 2025 for our dispensing solutions for the beauty, personal care, home care, food and beverage markets(1)

31

(1) This is an evolving target due to limited availability of material suitable for our market because of regulatory constraints and customers policies; Aptar is actively working to identify and qualify new technologies in this space.

32

A Safety First Mindset

• EHS Critical Rules• Behavior-Based Safety Program• Reduced both the Total Recordable

Incident Rate (TRIR) and Lost Time Frequency Rate (LTFR) by more than 20% from year-end 2018

Employee Engagement

Diversity and Inclusion • ATR included in the SPDR® SSGA Gender

Diversity Index ETF (SHE)

• Director Maritza Montiel named One of the 15 Most Influential Hispanic Leaders by Latino Leaders

• sHero Award for Best Place to Work for Female Executives in China

• Catalyst CEO Champions for Change

• Set the following initial diversity targets:– Women leaders to account for 30% of our leadership

team (VP level and above) by 2025– Aptar’s Global Leadership Team, which is comprised

of the most senior leaders in each business segment, along with Aptar’s Executive Committee, and all of their immediate direct reports will complete Diversity and Inclusion training by the end of 2020

33

Community Outreach

Midland Donation• With the support of the Aptar Charitable

Foundation, Aptar Midland donated to a local non-profit organization, Shelterhouse,

• Shelterhouse is a multi-service agency offering shelter, safety, support, advocacy and counseling services to survivors of domestic violence and sexual assault in Midland, Michigan and surrounding counties.

Narcan Donation• Aptar and Adapt Pharma collaborated

on the development of the nasal spray system for NARCAN®, delivering a dose of naloxone, assisting in drug overdose emergencies, without assembly or specialized medical training.

• Looking to address the opioid epidemic in their own community, the companies donated 5,000 doses making the potentially life-saving medication more accessible to those who need it.

Vatsalya Foundation• Aptar Mumbai (India) has partnered with

the Vatsalya foundation since 2010.• The foundation works with street children in

India to provide outreach, services and shelter.

• In 2018, the team in India invited the children to visit the offices for a day filled with activities, traditional games and more.

• Aptar employees spent the day connecting and working with the children.

34

Leadership & Talent Development

35

In 2019, Aptar launched it’s first Technical Education Center in Lincolnton, North Carolina• Designed to tech and train technical talent• 6 and 12 month apprenticeships• 50% of time in the Technical Education

Center / 50% at home factory shop floor

Aptar Corporate University

• CASA – Global Leadership Program• CASITA – Regional mid-level• Greenhouse – Regional young

professionals• LaFabbrica – Local manufacturing

leadership program• Immersive in person group training +

eLearning

36

Employee Engagement• Annual Leadership for Growth

Employee Survey focused on career advancement, job satisfaction, diversity and leadership

• 78% Participation Rate

• Open dialogue around the company’s Vision and Strategic Priorities

37

Stephan Tanda George L. Fotiades

Giovanna Kampouri Monnas Maritza Montiel Andreas Kramvis

B. Craig Owens Jesse Wu Dr. Joanne C. Smith

Isabel Marey-Semper Ralph Wunderlich

• 9 of 10 directors are independent• Separate independent Chairman & CEO• 30% of the Board is comprised of directors added

in the past 2 years • (50% in the past 5 years) as of the end of

2019• 40% of our directors are women; all Board

Committees are chaired by women directors• Majority voting for directors and director

resignation policy in uncontested elections• Director age limits• Independent directors meet regularly in

executive session• Annual Board and Committee self-evaluations• Annual ‘‘Say-on-Pay Vote’’ on executive

compensation• Stock ownership requirements for directors and

executive officers• Prohibits directors and executive officers from

hedging or pledging stock

Board of Directors

38

Aptar Pharma

39

SALES BY REGION

67%27%

2%

4%

SALES BY MARKET

50%

24%

16%

10% Prescription

ConsumerHealth CareInjectables

ActivePackaging

CUSTOMERS (Approx. 1500)

INNOVATIVE SOLUTIONS

PATENTS

PATIENT / CONSUMER EXPERIENCE

Aptar Pharma Today

8 BillionOver

Solutions per Year

750Patent Families

Approximately

40

PharmaBroad Technology Portfolio

Dermal Injectable Inhalation Nasal

Eye Care Connected Active Packaging

A leader in drug delivery systems with a broad range of innovations across all routes of administration41

Innovations that Can Save LivesNasal Unidose Powder System and Activ-Polymer™ Container

First Needle-Free Rescue Treatment for Severe Hypoglycemia

First Aptar Pharma + Aptar CSP Technologiescombination offering

42

Aptar’s Unidose Nasal Powder Device

Needle and Syringe version

Aptar CSP Technologies

Active Polymer Technology

43

• Maintains integrity of the contents inside

• Extends shelf-life • Controls moisture and reduces

oxygen

• Removes gasses from interior of the package environment

• Removes odor/other harmful contaminants

Expanding our offering from drug delivery devices and components to being a full service provider for our customers, from product development through the post-launch stage

Aptar Pharma Services

44

Guiding you through every step of drug product development

Device & formulation

developmentClinical trials Regulatory filings Market launch &

post-launch

A global leader in patient onboarding and adherence programs.

A leading provider of orally inhaled & nasal drug product design & development services.

A full-service cGMPlab specializing in analytical testing of drug delivery systems.

A full-service cGMP lab providing industry-leading particulate detection & predictive analytical services.

A global provider of innovative drug delivery systems and service solutions.

Aptar Pharma Services

Proven Regulatory Experience• 25+ years experience of

supporting our customers’ regulatory submissions

• Fast approval drug delivery device data packages

• Successful track record with multiple regulatory agencies

45

Aptar Pharma

Key Growth Drivers

CONVERSION & LIFECYCLE MANAGEMENTNon-dispensed solutions to dispensed device solutions is broad-based across prescription, consumer health care and injectables

NEW APPLICATION FIELDSEnter in new application fields (pain and CNS) with innovative devices (UDS, BDS)

SERVICES EXPANSIONPursue geographical expansion in appropriate markets and develop new revenue streams (services, digital health)

LEGACY APPLICATION FIELDSStrengthen our leadership position in legacy application fields (Asthma, COPD, Allergic Rhinitis)

46

Aptar Pharma

Full Year 2019 Results

47

(1) Excludes acquisitions and currency effects. (2) Adjusted EBITDA (earnings before net interest, taxes,

depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting adjustments.

36% 36%

0%

10%

20%

30%

40%

YTD 2018 YTD 2019

Adjusted EBITDA(2) Margin%

$955$1,091

$0

$200

$400

$600

$800

$1,000

$1,200

YTD 2018 YTD 2019

$ in

milli

ons

Sales

Reported

+14%Core 10%

Acquisitions 9%

Currency Effects

-5%

Metric3 Year

Average 2019

Long-term

TargetCore sales growth1 10% 10% 6-10%

Adj. EBITDA2 margin 35% 36% 32-36%

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Aptar Pharma

5 Year Financials

48

$712 $741 $806$955

$1,091

$0

$500

$1,000

$1,500

2015 2016 2017 2018 2019

Sales(in millions $)

$247 $259 $276

$344$387

$0

$100

$200

$300

$400

$500

2015 2016 2017 2018 2019

Adjusted EBITDA(in millions $)

Adjusted EBITDA (earnings before net interest, taxes, depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting adjustments.

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Aptar Beauty + Home

49

SALES BY REGION (YTD 2019)

58%23%

12%

7%

SALES BY MARKET (YTD 2019)

51%41%

8%

Beauty

Personal Care

Home Care

CUSTOMERS (6,000+)

INNOVATIVE SOLUTIONS

PATENTS

CONSUMER EXPERIENCE

16 BillionOver

Solutions per year

400Patent Families

50

Aptar Beauty + Home Today

Over

A significant amount of Europe sales end up in Asia in luxury and travel

Beauty + HomeBroad Technology Portfolio

Fine Mist Pumps

Bag-on-Valves On The Go Fragrance

Dispensing

Metered Dose Valves

Lotion Dispensers

Dispensing Closures

SofTipsDirect

Application

Cosmetic Pumps

Airless Systems Precise

Applicators

Sampling + Promotion

A leader in brand differentiating solutions and value-added convenience 51

Innovation that Improves LivesClarins Double Serum

New packaging delivers the right dose of the dual serum to apply to the face in a single pump

Push button can also be rotatedto offer consumers a different dose to match their needs, while controlling the amount of the two formulas each time the product is used

52

1985 1996 2007

Today

Aptar Beauty + Home

Key Growth Drivers

SUSTAINABLE SOLUTIONSExploring additional opportunities for sustainable resins and well positioned to help our customers achieve their sustainability goals

E-COMMERCESolutions designed to withstand rigorous e-commerce shipping and handling

COLOR COSMETICSChina driving growth along with booming indie brands

GEOGRAPHIC GROWTHAsia as a growth engine for global beauty, personal care and home care markets

53

Aptar Beauty + Home

Full Year 2019 Results

54

(1) Excludes acquisitions and currency effects. (2) Adjusted EBITDA (earnings before net interest, taxes,

depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting

adjustments.

$1,426 $1,353

$0

$200

$400

$600

$800

$1,000

$1,200

$1,400

$1,600

YTD 2018 YTD 2019

$ in

milli

ons

Sales

Reported

-5%Core -1%

Acquisitions 0%

Currency Effects

-4%

Metric 3 Year Average 2019 Long-term

Target

Core sales growth(1) 3% -1% 3-6%

Adj. EBITDA(2) margin 13% 13% 15-17%

13% 13%

0%

4%

8%

12%

16%

YTD 2018 YTD 2019

Adjusted EBITDA(2) Margin %

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Aptar Beauty + Home

5 Year Financials

55

$1,273 $1,261 $1,314 $1,426 $1,353

$0

$500

$1,000

$1,500

$2,000

2015 2016 2017 2018 2019

Sales(in millions $)

$174$187

$173 $181

$0

$50

$100

$150

$200

$250

2015 2016 2017 2018 2019

Adjusted EBITDA(in millions $)

$186

Adjusted EBITDA (earnings before net interest, taxes, depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting adjustments.

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Aptar Food + Beverage

56

SALES BY REGION (YTD 2019)

28%55%

8%

9%

SALES BY MARKET (YTD 2019)

68%32%Food

Beverage

CUSTOMERS (>200 clients with top 20 representing 65% of sales)

INNOVATIVE SOLUTIONS

PATENTS

CONSUMER EXPERIENCE

Aptar Food + Beverage Today

7 BillionOver

Solutions per Year

150Patent Families

Over

57

Food + BeverageBroad Technology Portfolio

BAP®

Bonded Aluminum to

Plastic

SimpliSqueeze® BOV® Bag On Valve

Pouch Fitments

PumpsDispensing Closures

Beverage Closures

Active Packaging

A leader in market intelligence-driven dispensing and sealing innovations58

Innovative Solutions that are SustainableUncle Dougie’s Barbeque Sauce

Pouches Can Reduce Environmental Impact by up to 80% Compared to Glass Bottles

Reduce fossil fuel usage by 65%

Reduce greenhouse emissions by 78%

Reduce overall water usage by 80%

59

Aptar’s Flip-Top Dispensing Closure and SimpliSqueeze Valve are

featured on the pouch

Source: Natural Marketing Institute (NMI)

Innovative Solutions that Can Improve LivesAntimicrobial

Foodborne disease facts:

600 Million fall ill (1 in 10) 220 Million are children

420,000 deaths globally 125,000 are children under

5 years old

$95 Billion lost productivity

60

99.9% elimination

of pathogenicity

Source: Financial Times

Patented Three Phase Antimicrobial

Platform Technology

Packaging agnostic

integrated solutions

Achieving up to 4 log pathogen

reduction

Proven technology

against Salmonella,

E.coli, ListeriaHuman

Norovirus

Aptar Food + Beverage

Key Growth Drivers

CONVERSIONFlat caps → dispensing solutions | Tubs & jars → flexible solutionsGlobal focus especially high-growth economies like China, India, Southeast Asia & Latin America

INNOVATIONKey Markets: Sauces & Condiments, Infant Nutrition & Water. Leveraging technologies such as Flip Lid, Karma, StandCap Inverted Pouch, BAP® & CSP.

SUSTAINABILITYSustainability global commitments: mono-material, solutions designed for recycling or to be reused, stay-with tethered solutions &Post-Consumer Recycled Resin (PCR)

GEOGRAPHIESAdapted strategy push in China. Shape markets in India & Indonesia. Tap into high value & sophisticated Japan & Korea markets.

61

Aptar Food + Beverage

Full Year 2019 Results

62

(1) Excludes acquisitions and currency effects. (2) Adjusted EBITDA (earnings before net interest, taxes,

depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting

adjustments.

$384$416

$0

$60

$120

$180

$240

$300

$360

$420

YTD 2018 YTD 2019

$ in

milli

ons

Sales

Reported+8%

Core 3%

Acquisitions7%

Currency Effects

-2%

Metric3 Year

Average 2019Long-term

TargetCore sales growth(1) 5% 3% 6-10%

Adj. EBITDA(2) Margin 16% 16% 18-21%

15%16%

0%

5%

10%

15%

20%

YTD 2018 YTD 2019

Adjusted EBITDA(2) Margin %

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Aptar Food + Beverage

5 Year Financials

63

$332 $328 $350$384

$416

$0

$100

$200

$300

$400

$500

2015 2016 2017 2018 2019

Sales(in millions $)

$64 $62 $63 $68

$0

$25

$50

$75

$100

2015 2016 2017 2018 2019

Adjusted EBITDA(in millions $)

$58

Adjusted EBITDA (earnings before net interest, taxes, depreciation and amortization) excludes restructuring costs, acquisition costs, non-recurring purchase accounting adjustments.

* See accompanying slide titled: Forward Looking Statements & Non-GAAP Financial Measures.

Forward Looking Statements and Non-GAAP Financial Measures

64

This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management’s beliefs and assumptions in light of information currently available to management. Accordingly, the Company’s actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in the Company’s operations and business environment, including, among other factors, those described in documents filed by the Company with the Securities and Exchange Commission, specifically its Form 10-Ks and 10-Qs. The Company does not assume any obligation to update, amend or clarify such statements to reflect new events, information or circumstances after the date of this presentation.

During the course of this presentation, certain non-GAAP financial information will be presented.

A reconciliation of those numbers to GAAP financial measures is available on the company’s website at www.aptar.com on the Investor’s page (click onEvents & Presentations / Presentations).

Follow us on:

265 Exchange DriveSuite 100

Crystal Lake, IL 60014+1 815-477-0424

aptar.com